Osteo Science Foundation was founded in 2013 by Dr. Peter Geistlich and Geistlich Pharma to advance hard and soft tissue regeneration in Oral and CranioMaxillofacial Surgery in North America. The foundation is now expanding to include global programming, extending programs and activities to serve Oral and CranioMaxillofacial Surgeons around the world.
Geistlich Pharma – a pioneer of regenerative dentistry – has successfully established ten of its twelve global subsidiaries in the past 16 years. Its dynamic development in the international markets has led to the construction of a new production building at its headquarters in Wolhusen. On August 30, the result of this investment amounting to the tens of millions was inaugurated in the presence of numerous guests.
Imagine if osteoarthritis of the knee, which so many people suffer from following partial meniscal resection, could be successfully combated? Geistlich Pharma is taking on the challenge of finding innovative ways to do this in cooperation with eleven other partners.
Geistlich Pharma is launching its own organization in Japan in early June. Aside from selling through the webshop and conventional channels, Geistlich is focusing on its longstanding commitment to education and training.
Geistlich Pharma set itself tough targets for 2018 but the figures now in show that the company delivered on all of them. What is particularly good news is that the success was spread across all three business units and was broad-based in geographical terms.
Geistlich Biomaterials has been publishing clinical treatment concepts for more than ten years – explained and commented on by surgeons themselves. Geistlich Indication Sheets are standard literature in dental practices worldwide.
If “Mercy Ships” didn’t exist, someone would have to invent them! The eponymous international aid organization gives hope to patients who are unable to access medical services, particularly specialist surgery.